The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients

Rezan Aksoy, (Sağlık Bilimleri Üniversitesi, Kartal Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Kalp Damar Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
Taylan Adademir, (Sağlık Bilimleri Üniversitesi, Kartal Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Kalp Damar Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
Deniz ÇEVİRME, (Sağlık Bilimleri Üniversitesi, Kartal Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Kalp Damar Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
Ekrem YILMAZ, (Sağlık Bilimleri Üniversitesi, Kartal Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Kalp Damar Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
Mehmet ŞENGÖR, (Sağlık Bilimleri Üniversitesi, Kartal Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Kalp Damar Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
Cengiz KÖKSAL, (Bezmialem Vakıf Üniversitesi, Tıp Fakültesi, Kalp Damar Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
Murat Bülent RABUŞ (Sağlık Bilimleri Üniversitesi, Kartal Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Kalp Damar Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
Clinical and Experimental Health Sciences
3 4
Yıl: 2021 Cilt: 11 Sayı: 1 Sayfa Aralığı: 34 - 41 Metin Dili: İngilizce DOI: 10.33808/clinexphealthsci.782816 İndeks Tarihi: 11-01-2022

The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients

Öz:
Objective: The aim of this study is to evaluate the gender specific effects of the high HbA1c levels in poorly controlled diabetic patients undergoing isolated coronary artery bypass grafting (CABG) procedure on long term morbidity, mortality and re-revascularization (2ndintervention). Methods: This study was conducted on 532 (346 (65%) males and 186 (35%) females) diabetic patients who underwent CABG procedure at a single center between January 2010 and December 2013.The patients were separated into 4 groups according to gender and preoperative HbA1c level (%). The group1 consisted of females with HBA1c level ≤7(n=46); the group 2 comprised female with HbA1c level >7(n=140); the group 3 comprised men with HbA1c level ≤7(n=117); and the group 4 comprised men with HbA1c level >7(n=229). The groups were analyzed and compared for postoperative complications and mortality. Results: No statistically significant difference was found among the groups in HbA1c levels and gender with respect to postoperative infection and mortality (p>0.05). The HbA1c level was determined to be statically significant and required the 2ndintervention (p:0.001; 95% CI: 1.249 (1.055,1.478)). Conclusion: This study suggested that there was no difference in mortality rates after CABG among the groups although the current risk calculator modules stated otherwise. However, the HbA1c levels were associated with a need for a secondary intervention on long term follow up period.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1] Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 non diabetic patients undergoing coronary artery bypass grafting. Ann ThoracSurg 2002;74:712-719.
  • [2] Thourani VH, Weintraub WS, Stein B, Gebhart SSP, Craver JM, Ellis LJ, Guyton RA. Influence of diabetes mellitus on early and late outcame after coronary artery bypass grafting. Ann Thorac Surg 1999;67:1045-1052.
  • [3] Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002;40:418-423.
  • [4] Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med 2000;342:1040-1042.
  • [5] Ikeda F, Doi Y, Ninomiya T, Hirakawa Y, Mukai N, Hata J, Shikata K, Yoshida D, Mostsumoto T, Kitazono T, Kiyohara Y. Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study. Cardiovasc Diabetol. 2013;12:164.
  • [6] Natali A, Vichi S, Landi P, Severi S, L’Abbate A, Ferrannini E. Coronary atherosclerosis in type II diabetes: angiographic findings and clinical outcome. Diabetologia 2000;43:632-641.
  • [7] Zheng, J., Cheng, J., Wang, T., Zhang, Q., & Xiao, X. Does HbA1c level have clinical implications in diabetic patients undergoing coronary artery bypass grafting? A systematic review and meta-analysis. International Journal of Endocrinol 2017; 1537213
  • [8] Faritous Z, Ardeshiri M, Yazdanian F, Jalali A, Totonchi Z, Azarfarin R. Hyperglycemia or high hemoglobin A1C: Which one is more associated with morbidity and mortality after coronary artery bypass graft surgery? Ann Thorac Cardiovasc Surg 2014; 20: 223–228.
  • [9] Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1–138.
  • [10] Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001 Apr; 163(5):1256-1276.
  • [11] Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P. Follow-up report on the diagnosis of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26(11):3160-167.
  • [12] Catapano, AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes WA, Jennigs CS, Landmesser U, Pedersen TR, Reiner Z, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren M, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT, ESC Scientific Document Group. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37(39):2999–3058.
  • [13] Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10 Suppl 2(Supplement 2):21–33.
  • [14] Lazar HL. How important is glycemic control during coronary artery bypass? Adv Surg 2012;46:219-35.
  • [15] The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217–225.Erratum, N Engl J Med 1997;336:147.
  • [16] Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, Piegas L, Calvin J,Keltaj M, Budaj A. Impact of diabetes on longterm prognosis in patients with unstable angina and non–Qwave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102(9):1014–9.
  • [17] Melidonis A, Dimopoulos V, Lempidakis E, Hatzissavas J, Kouvaras G, Stefanidis A, Foussas S. Angiographic study of coronary artery disease in diabetic patients in comparison with nondiabetic patients. Angiology 1999;50: 997-1006.
  • [18] Abaci A, Oğuzhan A, Kahraman S, Eryol NK, Unal S, Arinç H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99(17):2239-2242.
  • [19] Czech B, Kucewicz-Czech E, Pacholewicz J, Wojarski J, Puzio J, Przybylski R, Farmas A, Ryfinski B, Zembala M. Original article Early results of coronary artery bypass graft surgery in women. Kardiologia Polska (Polish Heart Journal) 2007;65(6).
  • [20] Göksedef D, Ömeroğlu S, Balkanay O, Talas Z, Arapi B, Ipek G. Coronary artery bypass in women: what is really different? Turk Gogus Kalp Damar Cerrahisi Dergisi 2012;20(1):8-13 (Turkish)
  • [21] Rosamond W, Flegal K, Friday G, Furie K, Go A, GreenlundK, Haase N, Ho M, Howard V, Kissela V, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G,O’Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger P, Thom T, WasserthielSmoller S, Hong Y.Heart disease and stroke statistics-2007 update; a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e169-e171
  • [22] Marco SB, Kim MF, Silvia GP. Cardiovascular diseases in Women: a statement from the policy conference of the European Society of Cardiology European Heart Journal 2006; 27:994-1005.
  • [23] Kaya M, İyigün T, İyigün M, Bakır İ, Yeniterzi M. The results of coronary artery surgery in women and men under the age of 45. Turk gogus kalp damar cerrahisi derg. 2013;21(3):581- 587
  • [24] Blankstein R, Parker Ward R, Arnsdorf M, , Jones B, Lou YB, Pine M. Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery contemporary analysis of 31 midwestern hospitals circulation. 2005; 112:I-323–I-327
  • [25] Ennker IC, Albert A, Pietrowski D, Bauer K, Ennker J, Florath I. Impact of gender on outcome after coronary artery bypass surgery. Asian Cardiovasc Thorac Ann. 2009;17(3):253
  • [26] Kuhl J, Sartipy U, Eliasson B, Nystrom T, Holzmann MJ. Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus. Int J Cardiol 2016; 202:291-296.
  • [27] Halkos M, Lattouf O, Puskas J, Kilgo P, Cooper W, Morris C, Guyton RA, Thourani VA. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after artery bypass surgery. Ann Thorac Surg. 2008;86(5):1431-1437.
  • [28] Michael P. Robich, MD, MSPH, Alexander Iribarne, MD, MS, Bruce J. Leavitt, MD, David J. Malenka, MD, Reed D. Quinn, MD, Elaine M. Olmstead. Intensity of glycemic control affects long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg. 2019;107(2):477-484.
  • [29] Nystrom T, Holzmann MJ, Eliasson B, Kuhl J, Sartipy U. Glycemic control in type 1 diabetes and long-term risk of cardiovascular events or death after coronary artery bypass grafting. J Am Coll Cardiol. 2015;66(5):535-543.
  • [30] Gozdzik A, Letachowicz K, Grajek BB, Plonek T, Obremska M, Jasinski M, Gozdzik W. Application of strain and other echocardiographic parameters in the evaluation of early and long-term clinical outcomes after cardiac surgery revascularization. BMC Cardiovasc Disord. 2019;19(1):189.
  • [31] Cihan HB, Erdil N, Nisanoğlu N, Çolak C, Erdil F, EgeE, Battaloglu B. Does type II diabetes mellitus increase mortality and morbidity in coronary artery bypass surgery? Turkish J Thorac Cardiovasc Surg. 2005;13:93-98.
  • [32] Nicolini, F., Santarpino, G., Gatti, G., Reichart, D., Onorati, F., Faggian, Dalen M, Khdabendeh S, Fischlein T, Maselli D, Nardella S,Rubino SA, Feo MS, Salsano A, Gherli R, Mariscalco G, Kinnunen EM, Ruggieri VG, Biancari F. Utility of glycated hemoglobin screening in patients undergoing elective coronary artery surgery: Prospective, cohort study from the E-CABG registry. International Journal of Surgery 2018; 53:354-359
  • [33] Kocogulları CU, Tekeli Kunt A, Aksoy R, Duzyol C, Parlar H, Saskın H. Hemoglobin A1c levels predicts acute kidney injury after coronary artery bypass surgery in non-diabetic patients. Braz J Cardiovasc Surg. 2017;32:83-89.
  • [34] Hertzberg D, Sartipy U, Holzmann MJ. Type 1 and type 2 diabetes mellitus and risk of acute kidney injury after coronary artery bypass grafting. Am Heart J. 2015; 170(5):895-902.
APA AKSOY R, Adademir T, Çevirme D, YILMAZ E, ŞENGÖR M, Koksal C, RABUS M (2021). The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. , 34 - 41. 10.33808/clinexphealthsci.782816
Chicago AKSOY REZAN,Adademir Taylan,Çevirme Deniz,YILMAZ EKREM,ŞENGÖR MEHMET,Koksal Cengiz,RABUS MURAT BULENT The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. (2021): 34 - 41. 10.33808/clinexphealthsci.782816
MLA AKSOY REZAN,Adademir Taylan,Çevirme Deniz,YILMAZ EKREM,ŞENGÖR MEHMET,Koksal Cengiz,RABUS MURAT BULENT The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. , 2021, ss.34 - 41. 10.33808/clinexphealthsci.782816
AMA AKSOY R,Adademir T,Çevirme D,YILMAZ E,ŞENGÖR M,Koksal C,RABUS M The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. . 2021; 34 - 41. 10.33808/clinexphealthsci.782816
Vancouver AKSOY R,Adademir T,Çevirme D,YILMAZ E,ŞENGÖR M,Koksal C,RABUS M The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. . 2021; 34 - 41. 10.33808/clinexphealthsci.782816
IEEE AKSOY R,Adademir T,Çevirme D,YILMAZ E,ŞENGÖR M,Koksal C,RABUS M "The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients." , ss.34 - 41, 2021. 10.33808/clinexphealthsci.782816
ISNAD AKSOY, REZAN vd. "The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients". (2021), 34-41. https://doi.org/10.33808/clinexphealthsci.782816
APA AKSOY R, Adademir T, Çevirme D, YILMAZ E, ŞENGÖR M, Koksal C, RABUS M (2021). The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. Clinical and Experimental Health Sciences, 11(1), 34 - 41. 10.33808/clinexphealthsci.782816
Chicago AKSOY REZAN,Adademir Taylan,Çevirme Deniz,YILMAZ EKREM,ŞENGÖR MEHMET,Koksal Cengiz,RABUS MURAT BULENT The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. Clinical and Experimental Health Sciences 11, no.1 (2021): 34 - 41. 10.33808/clinexphealthsci.782816
MLA AKSOY REZAN,Adademir Taylan,Çevirme Deniz,YILMAZ EKREM,ŞENGÖR MEHMET,Koksal Cengiz,RABUS MURAT BULENT The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. Clinical and Experimental Health Sciences, vol.11, no.1, 2021, ss.34 - 41. 10.33808/clinexphealthsci.782816
AMA AKSOY R,Adademir T,Çevirme D,YILMAZ E,ŞENGÖR M,Koksal C,RABUS M The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. Clinical and Experimental Health Sciences. 2021; 11(1): 34 - 41. 10.33808/clinexphealthsci.782816
Vancouver AKSOY R,Adademir T,Çevirme D,YILMAZ E,ŞENGÖR M,Koksal C,RABUS M The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients. Clinical and Experimental Health Sciences. 2021; 11(1): 34 - 41. 10.33808/clinexphealthsci.782816
IEEE AKSOY R,Adademir T,Çevirme D,YILMAZ E,ŞENGÖR M,Koksal C,RABUS M "The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients." Clinical and Experimental Health Sciences, 11, ss.34 - 41, 2021. 10.33808/clinexphealthsci.782816
ISNAD AKSOY, REZAN vd. "The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients". Clinical and Experimental Health Sciences 11/1 (2021), 34-41. https://doi.org/10.33808/clinexphealthsci.782816
Sayfa Oluşturulma Tarihi
17-04-2024 22:54

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları